Induction of necrotic tumor cell death by TRAIL/Apo-2L

Author： Kemp T. J. Kim J.-S. Crist S. A. Griffith T. S.

ISSN： 1360-8185

Source： Apoptosis, Vol.8, Iss.6, 2003-12, pp. : 587-599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Death to the bad guys: Targeting cancer via Apo2L/TRAIL

By Bouralexis S.

Apoptosis, Vol. 10, Iss. 1, 2005-01 ,pp. : 35-51

Springer Publishing Company

Access to resources Recommend Favorite

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

By Almasan A. Ashkenazi A.

Cytokine and Growth Factor Reviews, Vol. 14, Iss. 3, 2003-06 ,pp. : 337-348

Elsevier

Access to resources Recommend Favorite

Induction of Cell Death by Cytokines in Cell Cycle-Synchronous Tumor Cell Populations Restricted to G 1 and G 2

By Breder J. Ruller S. Ruller E. Schlaak M. van der Bosch J.

Experimental Cell Research, Vol. 223, Iss. 2, 1996-03 ,pp. : 259-267

Elsevier

Access to resources Recommend Favorite

The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems

By Walczak H. Krammer P.H.

Experimental Cell Research, Vol. 256, Iss. 1, 2000-04 ,pp. : 58-66

Elsevier

Access to resources Recommend Favorite

Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor

By Ray S. Bucur O. Almasan A.

Apoptosis, Vol. 10, Iss. 6, 2005-12 ,pp. : 1411-1418

Springer Publishing Company

Access to resources Recommend Favorite